HALO
HALOZYME THERAPEUTICS, INC.
HALOZYME THERAPEUTICS, INC. (HALO) has 15 SEC Form 4 filings (75 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 9, 2026.
The most active filer is PRESIDENT AND CEO Torley Helen with 16 filings. Insiders have net sold $11.6M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Helen I. Torley
- Employees:350
- HQ:San Diego, CA, US
- IPO:2004-03-16
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$20.1M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$9.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| PRESIDENT AND CEO | Sale | 1,923 | $153K | Jul 9 | SEC ↗ | |
Connaughton BernadetteFirst filing | Director | Sale | 1,625 | $125K | Jul 2 | SEC ↗ |
Krishnan MaheshFirst filing | Director | Sale | 7,304 | $548K | Jun 30 | SEC ↗ |
| PRESIDENT AND CEO | Sale | 20,000 | $1.3M | May 13 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 20,000 | $1.4M | May 13 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 10,000 | $692K | May 13 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 20,000 | $1.4M | Mar 4 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 20,000 | $1.4M | Mar 4 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 10,000 | $702K | Mar 4 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 20,000 | $1.5M | Feb 5 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 20,000 | $1.5M | Feb 5 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 10,000 | $786K | Feb 5 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 20,000 | $1.4M | Nov 12 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 20,000 | $1.4M | Nov 12 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 20,000 | $1.4M | Nov 12 | SEC ↗ | |
Torley HelenFirst filing | PRESIDENT AND CEO | Sale | 20,000 | $1.5M | Oct 3 | SEC ↗ |
Torley HelenFirst filing | PRESIDENT AND CEO | Sale | 20,000 | $1.4M | Oct 3 | SEC ↗ |
Torley HelenFirst filing | PRESIDENT AND CEO | Sale | 20,000 | $1.4M | Oct 3 | SEC ↗ |
Related companies
HALOZYME THERAPEUTICS, INC. is in the Healthcare sector.